Fleming, C. W., Ward, M. C., Woody, N. M., Joshi, N. P., Greskovich, J. F., Rybicki, L., . . . Schwartzman, L. (2021). Identifying an oligometastatic phenotype in HPV-associated oropharyngeal squamous cell cancer: Implications for clinical trial design. Oral Oncology, 112, N.PAG. https://doi.org/10.1016/j.oraloncology.2020.105046
Chicago Style (17th ed.) CitationFleming, Christopher W., et al. "Identifying an Oligometastatic Phenotype in HPV-associated Oropharyngeal Squamous Cell Cancer: Implications for Clinical Trial Design." Oral Oncology 112 (2021): N.PAG. https://doi.org/10.1016/j.oraloncology.2020.105046.
MLA (9th ed.) CitationFleming, Christopher W., et al. "Identifying an Oligometastatic Phenotype in HPV-associated Oropharyngeal Squamous Cell Cancer: Implications for Clinical Trial Design." Oral Oncology, vol. 112, 2021, p. N.PAG, https://doi.org/10.1016/j.oraloncology.2020.105046.